Biotechnology firm Galapagos receives offers for cell-therapy business

Core Insights - Biotechnology firm Galapagos has received non-binding offers from consortia primarily made up of financial investors for its cell-therapy business [1] Company Summary - Galapagos' board is currently evaluating offers for its cell-therapy division, indicating potential strategic shifts or divestitures in its business model [1]